Nazione: Germania
Lingua: inglese
Fonte: HMA (Heads of Medicines Agencies)
cloprostenol 250 µg/ml
Virbac S.A.
QG02AD90
Injection
cloprostenol
Cattle Females
2010-10-15
_ _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cyclix 250 microgram/ml solution for injection for cattle SPAIN: Cyclix bovino 250 µg/ml solucion inyectable SWEDEN: Cyclix 250 mikrogram/ml injektionsvätska, lösning för nötkreatur THE NETHERLANDS: Cyclix 250 µg/ml oplossing voor injectie voor koeien UK/IRELAND: Cyclix 250 microgram/ml solution for injection for cattle AUSTRIA: Cyclix 250 µg/ml – Injektionslösung für Kühe ITALY: Cyclix bovini 250 µg/ml soluzione iniettabile 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: ACTIVE SUBSTANCE(S): Cloprostenol sodium 263 micrograms (corresponding to 250 micrograms cloprostenol) EXCIPIENTS: Chlorocresol 1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection Colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cows 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction of luteolysis allowing resumption of oestrus and ovulation in cyclic females when used during dioestrus, synchronisation of oestrus (within 2 to 5 days) in groups of cyclic females treated simultaneously, treatment of suboestrus and uterine disorders related to a functioning or persistent corpus luteum (endometritis, pyometra), treatment of ovarian luteal cysts, induction of abortion until day 150 of pregnancy, expulsion of mummified foetuses, induction of parturition. 4.3 CONTRAINDI Leggi il documento completo